October 13, 2022
Jay Weiker, Chair of the CDCB Board of Directors, shares the CDCB progress and priorities of the past year in the newly-published 2022 Activity Report.
October 5, 2022
CDCB recently published its 2022 Activity Report, recapping activity from October 2021 to September 2022 – with stats, milestones, R&D updates and messages from CDCB Chair Jay Weiker and CEO João Dürr.
A monthly newsletter, details genetic evaluation updates and industry news.